The First Cellular Rejuvenation Therapy in Clinical Trials with Michael Ringel, Ph.D., J.D.

Aging might not be inevitable. In this episode of Decoding Longevity, Dr. Michael Ringel (COO, Life Biosciences) explains how scientists are learning to “reset” the biological age of cells—without changing what they are. From reversing vision loss in preclinical models to launching one of the first human trials, this conversation explores a future where we don’t just treat diseases of aging—we target aging itself. 🔗 Show notes: * Life Biosciences: https://www.lifebiosciences.com/ * Clinical pipeline: https://www.lifebiosciences.com/pipeline/ * Michael Ringel talks: https://www.youtube.com/watch?v=XC31N9KbOEs / https://www.youtube.com/watch?v=OycGR-03S8A / https://www.youtube.com/watch?v=EZUBjXv5wIw